Navigation Links
Signalife Awarded New U.S. Patent, 'System For, And Method Of, Monitoring Heartbeats Of A Patient'
Date:4/23/2008

GREENVILLE, S.C., April 23 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex: SGN) has announced that the United States Patent and Trademark Office has awarded the Company a new and important patent entitled "System For, And Method Of, Monitoring Heartbeats Of A Patient". The patent, which covers 37 claims, will enhance the Company's ability to develop new proprietary products.

Patent attorneys from Fulwider & Patton supervised and executed the patent application along with Chief Technology Officer Budimir S. Drakulic -- the inventor of the patented technology. The new patent is owned by Signalife, Inc. In conjunction with the Patent Office's granting of the patent, the Company will now evaluate whether or not it will file a continuation or continuation-in-part application for the purpose of pursuing additional claim coverage in the technology that may have occurred since the time of the original application.

Budimir S. Drakulic called the patent-issuance-development a "major milestone in the continued proliferation and protection of the Company's core technologies and products." Dr. Drakulic continued to say that issued patents together with significant patent portfolio already submitted to the United States Patent Office and two Frost & Sullivan technology awards represent major achievements for a young medical device company.

The Company currently has several additional patents pending before the United States Patent and Trademark Office covering a wide array of cardiac technologies and products. Dr. Drakulic stated that he is "confident the Company will continue to be successful in obtaining approvals for pending patents of its technologies and products."

About Signalife

Signalife, Inc. is a life scienc
'/>"/>

SOURCE Signalife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Signalife Announces Webcast
2. AMEX Notifies Signalife That It Has Accepted Signalifes Plan of Compliance
3. Signalife Sees Accretive Purchase and Financial Commitments
4. Signalife Wins Second Frost & Sullivan Technology Award
5. Signalife & Athletes Foundation Dispatch Mobile Health Center to Super Bowl
6. AMEX Notifies Signalife that It Will Need to Comply with Minimum Stockholders Equity Requirement
7. Signalife Presence at XIII World Congress on Cardiac Pacing and Electrophysiology
8. U.S. Patent 7,299,083 Awarded to Signalife
9. Signalife Receives FDA Clearance for OTC Non-Prescription Event Recorder Device
10. Signalife Continues to Procure Purchase Orders, Revenues
11. NFL Hall of Fame Legend Fred Biletnikoff Joins AFL/Signalife Cardiovascular Protection Team

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...ire-FirstCall/ -- Stallergenes has been,granted Eu...s and children,through a Mutual Recognition Proced...as been marketed, was the reference Member state. ..., Belgium, Bulgaria, Cyprus, the,Czech Republic, E... Italy,Latvia, Lithuania, Luxembourg, Malta, the ...
(Date:11/25/2009)...re/ -- Biotech firm Replikins Ltd., which has anal...ndemic through the prediction, outbreak, and progr... latest biochemical analysis of the virus. The new... Flu") virus has dropped from its peak of 3.7 (s.d...spring of 2009 to resting non-epidemic levels this...
(Date:11/25/2009)...Newswire-Asia/ -- Sinovac Biotech Ltd. ( SVA),a l...ed today that it executed,a joint venture (JV) agr...ology Co., Ltd. (Sinovac Dalian). The JV will rese... vaccines. Sinovac will contribute its expertise,a...rld-class vaccines; the,other party will bring its...
(Date:11/24/2009)...e-FirstCall/ -- IES (Nasdaq: IESC ), a leading na...ystems and services for the commercial, industrial... commercial business group has been awarded a cont...rical systems for the Level 4 bio-safety lab (BSL-...esearch Institute of Infectious Diseases (USAMRIID...
Breaking Biology Technology:STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2
...9 The 2009 Frost & Sullivan European Drug Dis...nometrix AG in recognition of its active role in t...toxicity assays. , , (Logo: http://www.newscom...t kits, used in the early screening stages of drug...overy and development through lead optimisation. O...
...March 18 Nile Therapeutics, Inc. (Nasdaq: NLTX ...herapeutics for heart failure patients, today anno...50(b)(1)(B), its audited financial statements for ...in the Company,s Annual Report on Form 10-K, filed...ification from its independent registered public a...
...., March 18 Idenix Pharmaceuticals, Inc. (Nasdaq:...the discovery and development of drugs for the tre...at four abstracts from the company,s hepatitis C a...een accepted for presentation at the 44th Annual M...f the Liver (EASL, April 22-26, 2009 in Copenhagen...
Other Biology Technology:Frost & Sullivan European Drug Discovery Product Innovation Award Bestowed on Xenometrix AG 2Frost & Sullivan European Drug Discovery Product Innovation Award Bestowed on Xenometrix AG 3Nile Therapeutics Announces Information in Compliance With NASDAQ Marketplace Rule 4350 and Reiterates 2009 Objectives 2Nile Therapeutics Announces Information in Compliance With NASDAQ Marketplace Rule 4350 and Reiterates 2009 Objectives 3Idenix Announces Data Presentations from Three HCV Discovery and Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL) 2Idenix Announces Data Presentations from Three HCV Discovery and Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL) 3
(Date:11/25/2009)...e heart pumps some 250 million liters of blood thr... fibers of the heart have to be extremely durable....er, vice chair of the Department of Medicine III a...Dr. H. A. Katus), has discovered a protein that is...cular unit, the sarcomere. In cooperation with oth...
(Date:11/24/2009)...rs to understanding how sounds associated with Nav...l or if they hear it at all. , The same type of...ses to detect flaws in the space shuttle,s behemot... peek inside the giant head of a whale. The scans ...of a whale,s hearing anatomy using a breakthrough ...
(Date:11/24/2009)...r 24, 2009) -- The Wildlife Conservation Society (...ast remaining population of Siberian tigers has li... of poaching and habitat loss. , WCS...s of what needs to be done to protect remaining po... The report was released by the Siberian Tiger...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Rocket science leads to new whale discovery 2Report shows dramatic decline in Siberian tigers 2Reviews of microbial gene language published in special issue of Trends in Microbiology 9269 1Reviews of microbial gene language published in special issue of Trends in Microbiology 9269 2Reviews of microbial gene language published in special issue of Trends in Microbiology 9269 3Reviews of microbial gene language published in special issue of Trends in Microbiology 9269 4CareFusion Prices 241 4 Billion of Senior Notes 51725 1CareFusion Prices 241 4 Billion of Senior Notes 51725 2Federal Judge Orders Schwarzenegger Administration to Comply with Order That Blocks State Reduction for IHSS Worker Wages 51721 1Federal Judge Orders Schwarzenegger Administration to Comply with Order That Blocks State Reduction for IHSS Worker Wages 51721 2
...re examining a way of using bacteria to manufactur...are difficult to create synthetically on a lab ben...lly produce antibiotics called prodiginines. , ...nt interest as they can be used to target and kill...lled GX15-070 is currently in phase 1 and 2 cancer...
...r "crystal meth" while in the womb, reveals an ana... the Fetal and Neonatal Edition of Archives of Dis...ly used detection methods (blood and urine), canno...inguish among different drugs, say the authors. Bl...he chemical evidence it holds. , Crystal meth b...
...the eye cancer retinoblastoma than mice because, u...activity of a gene critical to normal retinal deve...tigators at St. Jude Children,s Research Hospital....rnal BMC Biology, explains why humans with a defec...gh risk of developing cancer of the retina, or ret...
Other Biology News:Hair samples show babies can be exposed to 'crystal meth' while in the womb 2
...me provides excellent background information, deta...dy of major HIV proteins including: the HIV growth...egrase and protease. Expression of HIV proteins us... assays; HIV/CD4 interactions; transient assays fo...
Sheep Anti-Mouse TREM-2 Polyclonal Antibody, Unconjugated from R&D Systems
Rabbit Anti-Ferret Whole Serum Polyclonal Antibody, Unconjugated from Bethyl Laboratories
...ers versatile liquid handling platforms and flexib... wide variety of life science applications.The Fre...es (75, 100, 150 and 200 cm), giving all laborator... with their application needs. Each platform can...
Biology Products: